查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1998953

復甦設備市場：按設備類型、應用程式、最終用戶和銷售管道的全球市場預測，2026-2032年

Resuscitation Devices Market by Device Type, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，復甦設備市場價值將達到 79.8 億美元，到 2026 年將成長至 84.3 億美元，到 2032 年將達到 116.9 億美元，複合年成長率為 5.59%。

主要市場統計數據
基準年 2025 79.8億美元
預計年份：2026年 84.3億美元
預測年份：2032年 116.9億美元
複合年成長率 (%) 5.59%

對技術、臨床需求和商業化之間的策略交匯點進行簡要概述，確定現代復甦設備的優先事項。

復甦設備在急診醫學、心臟護理和呼吸支援領域佔據著至關重要的地位，本執行摘要概述了影響創新、應用和採購的策略因素。科技的快速進步、對院外護理日益成長的關注以及在臨床和家庭環境中不斷擴展的應用場景，都提高了人們對去心房顫動、植入式設備和穿戴式治療方法的認知和戰略重要性。在此背景下，從產品開發到醫院採購的相關人員必須全面考慮臨床療效、監管合規性、報銷複雜性和分銷趨勢，才能保持競爭力。

小型化、互聯互通以及醫療領域的變革等協同進步，如何重新定義復甦設備的產品設計重點與競爭優勢？

在技​​術創新、醫療環境的擴展和臨床通訊協定的演進的推動下，復甦設備領域正經歷著變革性的轉變。首先，小型化和更高的能源效率使得更便攜、更易於使用的外部設備成為可能。同時，導線設計和電池化學方面的創新提高了植入式系統的耐用性和可靠性。此外，心律不整檢測演算法和自適應起搏邏輯的進步提高了臨床診斷的準確性，減少了不必要的干涉，並增強了患者安全性。

受關稅措施的影響，成本結構和籌資策略發生了重組，引發了策略供應鏈重組和籌資策略調整。

美國2025年實施的關稅措施引發了一系列成本和供應鏈趨勢，迫使製造商、經銷商和醫療保健系統進行策略調整。關稅導致投入成本上升，促使各機構重新審視籌資策略，重新評估供應商關係、近岸外包方案以及零件替代方案，以在控制成本風險的同時維持臨床績效。為此，一些製造商加快了替代供應商的認證進程，優先採用可實現在地採購的模組化設計，並加強了與長期採購協議和供應保證相關的談判。

全面的細分分析揭示了醫療設備類型、臨床應用、最終用戶環境和銷售管道如何共同塑造產品策略和商業性執行。

對市場區隔的深入理解揭示了每種醫療設備類型、臨床應用、最終用戶和銷售管道的不同開發管道和商業化策略。依醫療設備類型分類，競爭格局包括自動體外心臟去心房顫動(AED)、植入式心臟整流去顫器(ICD)、手動體外去心房顫動(MED) 和植入式心臟整流去顫器。在此範圍內，AED去心房顫動分為全自動和去心房顫動類型；ICD 包括雙心室、雙腔和單腔配置；MED 則提供攜帶式和固定式兩種形式。這些差異影響著產品設計重點、監管證據要求和上市後支援模式。植入式技術需要長期臨床數據，而體外設備則更注重易用性和可維護性。

影響美洲、歐洲、中東和非洲以及亞太地區招募和商業化策略的決策因素和市場進入趨勢。

區域趨勢對復甦設備的監管時間表、報銷機制和部署速度有顯著影響。在美洲，由於醫療保健系統中公私採購行為交織在一起，報銷機制的清晰度和與急救服務的整合是決定設備部署的關鍵因素。市場參與企業必須使其臨床證據產生和衛生經濟學訊息與支付方和醫院網路的優先事項保持一致，以促進採購和部署決策。

概述決定復甦技術領域競爭優勢的競爭對手策略、協作證據產生和能力獲取趨勢。

復甦設備領域的競爭格局由成熟的醫療設備製造商和新興的技術主導參與企業組成，各方都在產品創新、臨床夥伴關係和服務模式方面採取差異化的策略。成熟製造商憑藉可靠的臨床實驗室數據和完善的分銷網路維持市場佔有率，同時持續投資於植入式導線系統的改進、能量傳輸的最佳化以及設備耐用性的提升。同時，新參與企業則專注於軟體驅動的診斷、基於機器學習的心律不整檢測以及基於雲端的設備管理，旨在創造新的收入來源並加強上市後監測。

產業領導者應實施的可操作的商業性、監管和營運重點，以確保復甦設備市場的韌性、成長和滲透。

行業領導者應優先採取一系列切實可行的措施，以降低監管和供應鏈風險，同時最大限度地利用不斷變化的需求和技術進步帶來的好處。首先，他們應透過臨床諮詢小組和可操作的實際應用評估檢驗產品功能，使產品藍圖與臨床工作流程保持一致。這可以確保設計選擇滿足現場可用性要求，並顯著改善反應時間和患者療效。其次，他們應投資於模組化架構和供應商多元化，以減少對單一供應商的依賴，並在供應鏈中斷時實現快速零件更換。第三，他們應開發與儀器銷售相輔相成的整合數位服務，例如遠端監控、培訓平台和結果分析，以提高客戶維繫並創造持續的收入。

我們透明、多方面的研究途徑，結合了臨床醫生參與、監管審查和交叉檢驗的二次分析，為可操作的策略建議提供了支持。

本研究採用多面向方法，結合與關鍵相關人員的對話、整合二手研究資料以及系統性的政策審查，確保提供可靠且切實可行的見解。關鍵資訊透過與醫療保健專業人員、採購決策者和醫療設備工程師的結構化訪談收集，從而了解他們對器械性能、易用性挑戰和採購限制等方面的實際觀點。除這些定性對話外，還與監管專家進行了有針對性的諮詢，以解讀不斷更新的軟體、網路安全和上市後監管要求的指導意見。

為指導復甦醫療設備領域的領導決策，提供綜合見解和策略重點，整合臨床、商業性和營運方面的考量。

總之，復甦醫療設備領域正處於轉折點，產品創新、數位化整合和供應鏈韌性將共同決定競爭格局。設備演算法、連接性和外形規格的進步，使得臨床級性能能夠在更廣泛的醫療環境中得到應用；同時，不斷上漲的價格和採購壓力，也催生了對經濟高效且靈活的生產和分銷策略日益成長的需求。考慮到監管預期以及醫療系統採購實踐中存在的細微區域差異，市場准入和循證實踐計劃必須進行個性化客製化，以確保商業化的成功。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 銷售管道分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 復甦設備市場：依設備類型分類

  • 自動體外心臟去心房顫動
    • 全自動
    • 半自動
  • 植入式心臟整流去顫器
    • 雙心室型
    • 雙腔型
    • 單腔型
  • 手動體外心臟去心房顫動
    • 攜帶式的
    • 固定式
  • 去心房顫動

第9章 復甦設備市場：依應用領域分類

  • 心臟麻痹
    • 心臟起搏
    • 有氧版
    • 去心房顫動
  • 呼吸衰竭
    • 侵入性通氣
    • 人工復甦
    • 非侵入性通氣

第10章 復甦設備市場：依最終用戶分類

  • 門診部
  • 緊急醫療服務
  • 居家醫療
  • 醫院
  • 專科診所

第11章 復甦設備市場：依銷售管道分類

  • 離線
  • 線上

第12章 復甦設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 復甦設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 復甦設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國復甦設備市場

第16章：中國復甦設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ambu A/S
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Dragerwerk AG & Co. KGaA
  • GE HealthCare Technologies, Inc.
  • Getinge AB
  • Hamilton Medical AG
  • Koninklijke Philips NV
  • Medtronic plc
  • Mindray Medical International Limited
  • Nihon Kohden Corporation
  • ResMed Inc.
  • Smiths Group plc
  • Stryker Corporation
  • Teleflex Incorporated
  • ZOLL Medical Corporation
Product Code: MRR-3D2FD205BF84

The Resuscitation Devices Market was valued at USD 7.98 billion in 2025 and is projected to grow to USD 8.43 billion in 2026, with a CAGR of 5.59%, reaching USD 11.69 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.98 billion
Estimated Year [2026] USD 8.43 billion
Forecast Year [2032] USD 11.69 billion
CAGR (%) 5.59%

A concise orientation to the strategic intersection of technology, clinical demand, and commercialization that defines modern resuscitation device priorities

Resuscitation devices occupy an essential intersection of emergency medicine, cardiac care and respiratory support, and this executive summary synthesizes the strategic factors shaping innovation, adoption, and procurement. Rapid technological advances, heightened focus on out-of-hospital care, and expanding use cases in both clinical and home environments have elevated the visibility and strategic importance of defibrillators, implantable devices, and wearable therapies. Against this backdrop, stakeholders from product development to hospital procurement must reconcile clinical efficacy, regulatory pathways, reimbursement complexity, and distribution dynamics to remain competitive.

The landscape is characterized by accelerated product iterations, tighter integration with digital health platforms, and increasing emphasis on user-centered design that supports non-clinical responders. Meanwhile, interoperability with electronic health records and telemetry systems is becoming a de facto expectation rather than a differentiator. In this context, decision-makers need clarity on where clinical needs, regulatory constraints, and commercial opportunity converge. This introduction frames the subsequent sections by outlining the emergent trends, tariff-related impacts, segmentation insights, regional dynamics, competitor movements, and recommended actions that together form a practical playbook for leaders in the resuscitation device domain.

How converging advances in miniaturization, connectivity, and care setting shifts are redefining product design priorities and competitive advantage for resuscitation devices

The resuscitation device landscape is undergoing transformative shifts driven by technological innovation, expanded care settings, and evolving clinical protocols. First, miniaturization and power-efficiency gains have enabled more portable and user-friendly external devices while innovations in lead design and battery chemistry are extending the longevity and reliability of implantable systems. Concurrently, algorithmic advances in arrhythmia detection and adaptive pacing logic have improved clinical accuracy, reducing unnecessary interventions and enhancing patient safety.

Second, the expansion of care beyond tertiary hospitals into ambulatory care centers, homecare settings and community public spaces has reshaped product requirements. Resuscitation solutions must now balance clinical-grade performance with simplicity of operation, remote monitoring capability, and cost-effective maintenance. Third, software and connectivity have become central to device value propositions; cloud-enabled event reporting, remote diagnostics and device management platforms are integral to lifecycle support and post-market surveillance. Finally, regulatory agencies are increasingly focused on cybersecurity, software validation, and real-world performance data, which together demand cross-functional alignment between engineering, clinical, and regulatory teams. As a result, companies that integrate clinical evidence generation, digital services and flexible go-to-market models will gain sustainable competitive advantages.

Strategic supply chain reconfiguration and procurement adaptations prompted by tariff interventions that reshaped cost structures and sourcing strategies

The implementation of United States tariffs in 2025 introduced a set of cost and supply-chain dynamics that require strategic recalibration for manufacturers, distributors and health systems. Tariff-induced input cost increases have intensified scrutiny of sourcing strategies, prompting organizations to re-evaluate supplier relationships, nearshoring options and component-level substitutions that preserve clinical performance while managing cost exposure. In response, some manufacturers accelerated qualification of alternate suppliers, prioritized modular designs that allow localized sourcing, and intensified negotiations tied to longer-term purchase agreements and supply guarantees.

Beyond direct cost impacts, tariffs affected inventory planning and lead-time management, pushing procurement teams to adopt more sophisticated demand-forecasting practices and safety-stock strategies. This shift led to increased collaboration between sales and operations teams to align contract terms with production realities and to introduce more flexible manufacturing capacity where feasible. Additionally, the tariffs heightened the appeal of value-added services-such as bundled maintenance, extended warranties, and remote monitoring-to offset price sensitivity and preserve margins. Moving forward, resilient supply-chain design and transparent cost communication will be critical for maintaining market access and supporting long-term clinical adoption.

Comprehensive segmentation analysis revealing how device type, clinical application, end-user setting, and sales channel collectively shape product strategies and commercial execution

A nuanced appreciation of market segmentation illuminates distinct development pathways and commercialization strategies across device types, clinical applications, end users and sales channels. Based on device type, the competitive arena encompasses Automated External Defibrillators, Implantable Cardioverter Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators; within that scope, Automated External Defibrillators are subdivided into Fully Automatic and Semi Automatic variants, Implantable Cardioverter Defibrillators include Biventricular, Dual Chamber and Single Chamber configurations, and Manual External Defibrillators appear in Portable and Stationary formats. These distinctions influence product design priorities, regulatory evidence needs, and post-market support models, with implantable technologies demanding long-term clinical data and external devices focusing on ease of use and maintenance.

Based on application, clinical use cases center on Cardiac Arrest and Respiratory Failure; Cardiac Arrest management includes modalities such as Cardiac Pacing, Cardioversion and Defibrillation, whereas Respiratory Failure care spans Invasive Ventilation, Manual Resuscitation and Non Invasive Ventilation. These application-based differences drive device feature sets, integration requirements with airway and monitoring equipment, and training protocols for end users. Based on end user, the landscape spans Ambulatory Care Centers, Emergency Medical Services, Homecare environments, Hospitals and Specialty Clinics, each of which has distinct procurement cycles, clinical competencies and service expectations. Finally, based on sales channel, market access is achieved through Direct Sales, Distributors and Online Sales strategies, each requiring tailored commercial approaches from field-based clinical engagement to digital marketing and logistics optimization. Understanding the interplay among these segmentation dimensions enables targeted product roadmaps, differentiated value propositions and channel-specific commercial tactics that resonate with clinical and operational buyers.

Regional decision drivers and market access dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence adoption and commercialization strategies

Regional dynamics exert a powerful influence on regulatory timelines, reimbursement mechanisms, and adoption velocities for resuscitation devices. In the Americas, healthcare systems demonstrate a heterogeneous mix of private and public procurement behaviors, where reimbursement clarity and emergency medical services integration are key determinants of adoption. Market participants must align clinical evidence generation and health economics messaging to the priorities of payers and hospital networks in order to drive procurement and deployment decisions.

In Europe, Middle East & Africa, regulatory harmonization efforts and regional procurement consortia create both opportunities and complexities; manufacturers need differentiated regulatory strategies that respect local conformity assessment processes and emerging digital health requirements. In many markets across this region, public tenders and centralized purchasing platforms make pricing transparency and long-term service commitments decisive factors in vendor selection. In the Asia-Pacific region, rapid infrastructure investments, growing chronic disease burdens and expanding primary care capacity accelerate demand for both acute and ambulatory resuscitation solutions. However, market entry often requires careful navigation of local distribution partnerships, product localization, and country-specific regulatory and reimbursement pathways. By aligning commercial models with regional decision drivers, companies can prioritize market entry sequencing and resource allocation to maximize impact.

An overview of competitor strategies, collaborative evidence generation, and capability acquisition trends that define competitive advantage in resuscitation technologies

Competitive dynamics in the resuscitation device space are characterized by a mix of established medical device manufacturers and emerging technology-focused entrants, each pursuing differentiated strategies across product innovation, clinical partnerships and service models. Incumbent manufacturers continue to invest in incremental improvements to implantable lead systems, energy delivery optimization and device longevity, leveraging robust clinical trial data and established distribution networks to defend market share. At the same time, newer entrants emphasize software-enabled diagnostics, machine-learning driven arrhythmia detection and cloud-based device management to create adjacent revenue streams and enhance post-market surveillance.

Collaborations between device developers and large health systems or emergency medical services organizations are increasingly common, enabling real-world evidence generation and accelerated product refinement. Moreover, strategic acquisitions and licensing arrangements remain key mechanisms for companies seeking rapid capability enhancement in digital health, battery technology or telemetry. Amid these trends, successful players demonstrate strong cross-functional coordination between R&D, clinical affairs and commercial teams to shorten feedback loops and ensure that product enhancements map directly to demonstrable clinical or operational benefits. The competitive landscape thus rewards organizations that can couple clinical credibility with agile product development and scalable service delivery.

Actionable commercial, regulatory, and operational priorities that industry leaders should implement to secure resilience, growth, and adoption in resuscitation device markets

Industry leaders should prioritize a set of practical actions to capitalize on demand shifts and technological advances while mitigating regulatory and supply-chain risks. First, align product roadmaps with clinical workflows by validating features through clinician advisory panels and pragmatic, real-world evaluations. This ensures that design choices address frontline usability and translate to measurable improvements in response times and patient outcomes. Second, invest in modular architectures and supplier diversification to reduce single-source dependency and enable rapid component substitution when supply chain disruptions occur. Third, develop integrated digital services that complement device sales, such as remote monitoring, training platforms and outcome analytics, which can strengthen customer retention and create recurring revenue.

Fourth, adopt flexible commercial models that combine direct field engagement for high-acuity settings with distributor partnerships and e-commerce strategies for broader reach and cost efficiency. Fifth, proactively engage regulatory authorities on software and cybersecurity expectations to preempt compliance bottlenecks and accelerate approvals. Finally, build cross-functional go-to-market playbooks that link clinical evidence generation, health economics messaging and procurement value propositions to reduce sales cycles and improve win rates. By implementing these actions in a coordinated manner, organizations can improve resilience, accelerate adoption and sustain profitable growth.

A transparent multi-method research approach combining clinician engagement, regulatory review, and cross-validated secondary analysis to support actionable strategic recommendations

This research synthesis is grounded in a multi-method approach that combines primary stakeholder engagement, secondary literature synthesis and systematic policy review to ensure robust, actionable insights. Primary inputs were gathered through structured interviews with clinicians, procurement decision-makers, and device engineers to capture frontline perspectives on device performance, usability challenges and procurement constraints. These qualitative engagements were complemented by targeted consultations with regulatory specialists to interpret evolving guidance on software, cybersecurity, and post-market surveillance requirements.

Secondary sources were analyzed to contextualize technology trends, clinical practice updates and supply-chain developments. In addition, a cross-validation process reconciled primary insights with publicly available regulatory documents, clinical guidelines and device labelling to ensure factual consistency. Throughout the methodology, emphasis was placed on triangulation-validating findings across multiple independent sources-and on transparency regarding assumptions and limitations. This approach yields an analytical foundation that balances practical relevance with rigorous scrutiny, enabling confident recommendations for product development, market access, and commercial strategy.

Summative implications and strategic priorities that synthesize clinical, commercial, and operational considerations to guide leadership decisions in resuscitation devices

In conclusion, the resuscitation device domain is at an inflection point where product innovation, digital integration and supply-chain resilience collectively determine competitive outcomes. Advances in device algorithms, connectivity and form factor are making it possible to deliver clinical-grade performance in a wider range of care settings, while tariff and procurement pressures are sharpening the need for cost-effective, flexible manufacturing and distribution strategies. Regional nuances in regulatory expectations and health-system procurement practices require tailored market entry and evidence generation plans to ensure successful commercialization.

Decision-makers should therefore pursue integrated strategies that combine rigorous clinical validation, adaptable supply-chain architectures, and differentiated service offerings to create defensible market positions. Cross-functional alignment between engineering, clinical affairs and commercial teams is essential to translate technical capabilities into valued clinical outcomes and compelling procurement propositions. By focusing on these priorities and by engaging early with key stakeholders, organizations can accelerate adoption, mitigate risk and position themselves for sustained impact in the evolving resuscitation device landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Resuscitation Devices Market, by Device Type

  • 8.1. Automated External Defibrillators
    • 8.1.1. Fully Automatic
    • 8.1.2. Semi Automatic
  • 8.2. Implantable Cardioverter Defibrillators
    • 8.2.1. Biventricular
    • 8.2.2. Dual Chamber
    • 8.2.3. Single Chamber
  • 8.3. Manual External Defibrillators
    • 8.3.1. Portable
    • 8.3.2. Stationary
  • 8.4. Wearable Cardioverter Defibrillators

9. Resuscitation Devices Market, by Application

  • 9.1. Cardiac Arrest
    • 9.1.1. Cardiac Pacing
    • 9.1.2. Cardioversion
    • 9.1.3. Defibrillation
  • 9.2. Respiratory Failure
    • 9.2.1. Invasive Ventilation
    • 9.2.2. Manual Resuscitation
    • 9.2.3. Non Invasive Ventilation

10. Resuscitation Devices Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Emergency Medical Services
  • 10.3. Homecare
  • 10.4. Hospitals
  • 10.5. Specialty Clinics

11. Resuscitation Devices Market, by Sales Channel

  • 11.1. Offline
  • 11.2. Online

12. Resuscitation Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Resuscitation Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Resuscitation Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Resuscitation Devices Market

16. China Resuscitation Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ambu A/S
  • 17.6. Becton, Dickinson and Company
  • 17.7. Cardinal Health, Inc.
  • 17.8. Dragerwerk AG & Co. KGaA
  • 17.9. GE HealthCare Technologies, Inc.
  • 17.10. Getinge AB
  • 17.11. Hamilton Medical AG
  • 17.12. Koninklijke Philips N.V.
  • 17.13. Medtronic plc
  • 17.14. Mindray Medical International Limited
  • 17.15. Nihon Kohden Corporation
  • 17.16. ResMed Inc.
  • 17.17. Smiths Group plc
  • 17.18. Stryker Corporation
  • 17.19. Teleflex Incorporated
  • 17.20. ZOLL Medical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL RESUSCITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RESUSCITATION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RESUSCITATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES RESUSCITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA RESUSCITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RESUSCITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. GCC RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GCC RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 184. GCC RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 186. GCC RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. GCC RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 188. GCC RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 189. GCC RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. GCC RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. G7 RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. G7 RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 214. G7 RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. G7 RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 218. G7 RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. G7 RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. NATO RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. NATO RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. NATO RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 224. NATO RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 225. NATO RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. NATO RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 228. NATO RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. NATO RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES RESUSCITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA RESUSCITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)